Avadel Pharmaceuticals PLC (AVDL)
11.93
+0.27
(+2.32%)
USD |
NASDAQ |
Nov 22, 13:22
Avadel Pharmaceuticals Enterprise Value: 1.058B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.058B |
| November 20, 2024 | 970.08M |
| November 19, 2024 | 967.19M |
| November 18, 2024 | 966.71M |
| November 15, 2024 | 985.50M |
| November 14, 2024 | 1.051B |
| November 13, 2024 | 1.092B |
| November 12, 2024 | 1.201B |
| November 11, 2024 | 1.505B |
| November 08, 2024 | 1.470B |
| November 07, 2024 | 1.449B |
| November 06, 2024 | 1.408B |
| November 05, 2024 | 1.372B |
| November 04, 2024 | 1.366B |
| November 01, 2024 | 1.384B |
| October 31, 2024 | 1.425B |
| October 30, 2024 | 1.178B |
| October 29, 2024 | 1.179B |
| October 28, 2024 | 1.167B |
| October 25, 2024 | 1.175B |
| October 24, 2024 | 1.187B |
| October 23, 2024 | 1.208B |
| October 22, 2024 | 1.252B |
| October 21, 2024 | 1.227B |
| October 18, 2024 | 1.241B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.275B |
| October 16, 2024 | 1.210B |
| October 15, 2024 | 1.206B |
| October 14, 2024 | 1.203B |
| October 11, 2024 | 1.198B |
| October 10, 2024 | 1.183B |
| October 09, 2024 | 1.133B |
| October 08, 2024 | 1.155B |
| October 07, 2024 | 1.165B |
| October 04, 2024 | 1.195B |
| October 03, 2024 | 1.168B |
| October 02, 2024 | 1.192B |
| October 01, 2024 | 1.202B |
| September 30, 2024 | 1.198B |
| September 27, 2024 | 1.156B |
| September 26, 2024 | 1.142B |
| September 25, 2024 | 1.150B |
| September 24, 2024 | 1.159B |
| September 23, 2024 | 1.168B |
| September 20, 2024 | 1.219B |
| September 19, 2024 | 1.238B |
| September 18, 2024 | 1.243B |
| September 17, 2024 | 1.260B |
| September 16, 2024 | 1.258B |
| September 13, 2024 | 1.248B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
82.40M
Minimum
May 26 2022
1.720B
Maximum
May 03 2024
654.60M
Average
456.04M
Median
Dec 29 2022
Enterprise Value Benchmarks
| Jazz Pharmaceuticals PLC | 11.06B |
| Medtronic PLC | 129.24B |
| Alkermes PLC | 3.862B |
| Perrigo Co PLC | 6.985B |
| Iterum Therapeutics PLC | 31.18M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.625M |
| Revenue (Quarterly) | 50.02M |
| Total Expenses (Quarterly) | 50.35M |
| EPS Diluted (Quarterly) | -0.03 |
| Gross Profit Margin (Quarterly) | 87.70% |
| Profit Margin (Quarterly) | -5.25% |
| Earnings Yield | -6.37% |
| Normalized Earnings Yield | -6.464 |